EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB

Benjamin L Lampson, Ana S Ramίrez, Marta Baro, Lixia He, Mudra Hegde, Vidyasagar Koduri, Jamie L Pfaff, Ruth E Hanna, Julia Kowal, Nitin H Shirole, Yanfeng He, John G Doench und 3 weitere

Cell · 2024-04 · 187 (9) · 2209-2223.e16

DOI: 10.1016/j.cell.2024.03.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-04. Verfasst von Benjamin L Lampson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Hexosyltransferases, NF-kappa B, Membrane Proteins, Toll-Like Receptor 4. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor κB (NF-κB) plays roles in various diseases. Many inflammatory signals, such as circulating lipopolysaccharides (LPSs), activate NF-κB via specific receptors. Using whole-genome CRISPR-Cas9 screens of LPS-treated cells that express an NF-κB-driven suicide gene, we discovered that the LPS receptor Toll-like receptor 4 (TLR4) is specifically dependent on the oligosaccharyltransferase complex OST-A for N-glycosylation and cell-surface localization. The tool compound NGI-1 inhibits OST complexes in vivo, but the underlying molecular mechanism remained unknown. We did a CRISPR base-editor screen for NGI-1-resistant variants of STT3A, the catalytic subunit of OST-A. These variants, in conjunction with cryoelectron microscopy studies, revealed that NGI-1 binds the catalytic site of STT3A, where it traps a molecule of the donor substrate dolichyl-PP-GlcNAc2-Man9-Glc3, suggesting an uncompetitive inhibition mechanism. Our results provide a rationale for and an initial step toward the development of STT3A-specific inhibitors and illustrate the power of contemporaneous base-editor and structural studies to define drug mechanism of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HexosyltransferasesNF-kappa BMembrane ProteinsToll-Like Receptor 4Signal TransductionCRISPR-Cas SystemsLipopolysaccharidesHumansAnimalsMiceHEK293 CellsInflammationGlycosylationCryoelectron MicroscopyCatalytic DomainClustered Regularly Interspaced Short Palindromic Repeats

Stichwörter der Autor:innen

CRISPR screeningN-glycosylationNF-κBToll-like receptorsinhibition mechanismoligosaccharyltransferase

Substanzen

HexosyltransferasesNF-kappa BMembrane Proteinsdolichyl-diphosphooligosaccharide - protein glycotransferaseToll-Like Receptor 4LipopolysaccharidesSTT3A protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.
  • Institute of Molecular Biology and Biophysics, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland.
  • Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, USA.
  • Genetic Perturbation Platform, Broad Institute, Cambridge, MA 02142, USA.
  • Division of Hematology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Institute of Molecular Biology and Biophysics, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland. Electronic address: locher@mol.biol.ethz.ch.

Förderung

  • NCI NIH HHS

Zitieren

APA

Lampson, B. L., Ramίrez, A. S., Baro, M., He, L., Hegde, M., Koduri, V., Pfaff, J. L., Hanna, R. E., Kowal, J., Shirole, N. H., He, Y., Doench, J. G., Contessa, J. N., Locher, K. P., & Kaelin, W. G. (2024). Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB. Cell, 187(9), 2209-2223.e16. https://doi.org/10.1016/j.cell.2024.03.022

Vancouver

Lampson BL, Ramίrez AS, Baro M, He L, Hegde M, Koduri V, et al. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB. Cell. 2024;187(9):2209-2223.e16. doi:10.1016/j.cell.2024.03.022

BibTeX
@article{Lampson2024,
  author = {Lampson, Benjamin L and Ramίrez, Ana S and Baro, Marta and He, Lixia and Hegde, Mudra and Koduri, Vidyasagar and Pfaff, Jamie L and Hanna, Ruth E and Kowal, Julia and Shirole, Nitin H and He, Yanfeng and Doench, John G and Contessa, Joseph N and Locher, Kaspar P and Kaelin, William G},
  title = {Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {9},
  pages = {2209--2223.e16},
  doi = {10.1016/j.cell.2024.03.022}
}
Kostenlos starten →